Tumors in Epilepsy

Abstract

Primary brain tumors are common causes of focal epilepsy, accounting for 5% of new-onset seizures in adults and over 10% of lesional focal epilepsies. These epilepsies are often refractory to medical treatment, and high rates of seizure freedom can be achieved with gross total resections. However, the management strategy is not straightforward, and should be decided on a case-by-case basis in a multidisciplinary team, considering the natural history of the tumor, the likelihood of seizure freedom following surgical resection, the risks of surgery, and the impact of seizures on quality of life. In this review, the authors summarize the crucial factors that help to decide how to manage this challenging patient group.

Keywords

epilepsy - tumors - surgery

• References

• 1 Japp A, Gielen GH, Becker AJ. Recent aspects of classification and epidemiology of epilepsy-associated tumors. Epilepsia 2013; 54 (Suppl. 09) 5-11
• 2 Cowie CJ, Cunningham MO. Peritumoral epilepsy: relating form and function for surgical success. Epilepsy Behav 2014; 38: 53-61
• 3 Citow JS, Macdonald RL, Refai D. Comprehensive Neurosurgery Board Review. 2nd ed. New York, Stuttgart: Thieme; 2009
• 4 Luyken C, Blümcke I, Fimmers R , et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003; 44 (6) 822-830
• 5 Stupp R, Mason WP, van den Bent MJ , et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352 (10) 987-996
• 6 Cossu M, Fuschillo D, Bramerio M , et al. Epilepsy surgery of focal cortical dysplasia-associated tumors. Epilepsia 2013; 54 (Suppl. 09) 115-122
• 7 Pallud J, Capelle L, Huberfeld G. Tumoral epileptogenicity: how does it happen?. Epilepsia 2013; 54 (Suppl. 09) 30-34
• 8 Guerrini R, Rosati A, Giordano F, Genitori L, Barba C. The medical and surgical treatment of tumoral seizures: current and future perspectives. Epilepsia 2013; 54 (Suppl. 09) 84-90
• 9 Englot DJ, Berger MS, Barbaro NM, Chang EF. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia 2012; 53 (1) 51-57
• 10 Englot DJ, Berger MS, Barbaro NM, Chang EF. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 2011; 115 (2) 240-244
• 11 Ius T, Isola M, Budai R , et al. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 2012; 117 (6) 1039-1052
• 12 Sanai N, Chang S, Berger MS. Low-grade gliomas in adults. J Neurosurg 2011; 115 (5) 948-965
• 13 Kim JW, Park CK, Park SH , et al. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours. J Neurol Neurosurg Psychiatry 2011; 82 (2) 224-227
• 14 Schiff D. Low-grade gliomas. J Neurosurg 2011; 115 (5) 945-947 , author reply 947
• 15 van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 2009; 256 (9) 1519-1526
• 16 Weller M, Gorlia T, Cairncross JG , et al. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology 2011; 77 (12) 1156-1164
• 17 Bobustuc GC, Baker CH, Limaye A , et al. Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro-oncol 2010; 12 (9) 917-927
• 18 Bendersky D, Tedesco N, Christiansen S, García MdelC, Ciraolo C. Epilepsy due to a temporal ganglioglioma and its subsequent malignant transformation into a primitive neuroectodermal tumor. Surg Neurol Int 2012; 3: 79
• 19 Moazzam AA, Wagle N, Shiroishi MS. Malignant transformation of DNETs: a case report and literature review. Neuroreport 2014; 25 (12) 894-899
• 20 Rosenow F, Menzler K. Invasive EEG studies in tumor-related epilepsy: when are they indicated and with what kind of electrodes?. Epilepsia 2013; 54 (Suppl. 09) 61-65
• 21 Rosenow F, Lüders H. Presurgical evaluation of epilepsy. Brain 2001; 124 (Pt 9) 1683-1700
• 22 Rodionov R, Vollmar C, Nowell M , et al. Feasibility of multimodal 3D neuroimaging to guide implantation of intracranial EEG electrodes. Epilepsy Res 2013; 107 (1-2) 91-100
• 23 Sweet JA, Hdeib AM, Sloan A, Miller JP. Depths and grids in brain tumors: implantation strategies, techniques, and complications. Epilepsia 2013; 54 (Suppl. 09) 66-71
• 24 Santos MV, de Oliveira RS, Machado HR. Approach to cortical dysplasia associated with glial and glioneuronal tumors (FCD type IIIb). Childs Nerv Syst 2014; 30 (11) 1869-1874
• 25 Duffau H. The challenge to remove diffuse low-grade gliomas while preserving brain functions. Acta Neurochir (Wien) 2012; 154 (4) 569-574
• 26 De Witt Hamer PC, Robles SG, Zwinderman AH, Duffau H, Berger MS. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 2012; 30 (20) 2559-2565
• 27 Duffau H. Brain mapping in tumors: intraoperative or extraoperative?. Epilepsia 2013; 54 (Suppl. 09) 79-83
• 28 Thom M, Toma A, An S , et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 2011; 70 (10) 859-878